Tesofensine is a synthetic piperidine-based compound developed as a triple monoamine reuptake inhibitor (serotonin, norepinephrine, and dopamine). Originally investigated for neurodegenerative diseases such as Alzheimer’s and Parkinson’s, Tesofensine was later studied for its appetite-suppressing effects. By modulating central neurotransmitters, Tesofensine reduces hunger, increases satiety, and enhances energy expenditure. In clinical trials, it has demonstrated significant weight loss effects compared to placebo. Tesofensine remains experimental and is not FDA-approved for therapeutic use.
How It Is Used in Research Settings
- Studied for obesity and weight management due to strong appetite-suppressing effects.
- Explored for enhancing energy expenditure and fat oxidation in metabolic research.
- Investigated in neurological models for Alzheimer’s and Parkinson’s disease (early research focus).
- Examined for synergistic effects when combined with other metabolic or appetite-regulating compounds.
Proposed Uses (Research Areas)
- Obesity and advanced weight management research.
- Metabolic health and insulin resistance studies.
- Neurodegenerative disease models (Alzheimer’s, Parkinson’s).
- Appetite regulation and neurotransmitter modulation research.
How It Is Dosed in Research Settings
- Oral (Clinical Research): Human trials have studied doses of 0.25–1 mg daily, with 0.5 mg showing optimal weight-loss efficacy.
- Cycle length: Clinical studies typically run 24–48 weeks to assess long-term weight and metabolic effects.
- Handling: Supplied in capsule form for research; stored in controlled room temperature conditions.
Important Considerations
- Regulatory status: Tesofensine is not FDA-approved; it remains in the research and clinical trial stage.
- Evidence base: Phase 2 trials in obesity demonstrated significant weight loss (up to 10%+ body weight), but cardiovascular and neurological safety remain under investigation.
- Safety: Reported research side effects include dry mouth, insomnia, nausea, constipation, and increased heart rate or blood pressure. Long-term safety requires more study.
Disclaimer
This material is provided for educational purposes only and summarizes published research on Tesofensine (MCG).
It is not medical advice. Tesofensine is experimental, not FDA-approved, and should not be viewed as a therapy for medical use.
This compound is for research use only.